Preferred Label : Leukemia, acute lymphoblastic;
Symbol : ALL;
CISMeF acronym : ALL;
Type : Phenotype or locus, molecular basis unknown;
Included titles and symbols : Leukemia, acute lymphoblastic, susceptibility to, 1; All1; Leukemia, acute lymphocytic, susceptibility to, 1; Leukemia, t-cell acute lymphoblastic, susceptibility to; Leukemia, b-cell acute lymphoblastic, susceptibility to; Leukemia, acute lymphoblastic, b-hyperdiploid, susceptibility to;
Description : Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a
subtype of acute leukemia, a cancer of the white blood cells. Somatically acquired
mutations in several genes have been identified in ALL lymphoblasts, cells in the
early stages of differentiation. Germline variation in certain genes may also predispose
to susceptibility to ALL (Trevino et al., 2009). - Genetic Heterogeneity of Acute
Lymphoblastic Leukemia A susceptibility locus for acute lymphoblastic leukemia (ALL1)
has been mapped to chromosome 10q21. See also ALL2 (613067), which has been mapped
to chromosome 7p12.2; and ALL3 (615545), which is caused by mutation in the PAX5 gene
(167414) on chromosome 9p.;
Prefixed ID : %613065;
Origin ID : 613065;
UMLS CUI : C1961102;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)